SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Siemens Healthineers and Novo partner on MASLD and MASH care

Siemens Healthineers and Novo said they have agreed to work together to improve care for patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH).

NOVOBSIE